Thermo Fisher launches CE-IVD marked TaqPath respiratory viral select panel
11 July 2022 | News
The PCR assay panel tests for five respiratory viruses in under three hours
Image Credit: Shutterstock
Thermo Fisher Scientific has launched Applied Biosystems TaqPath Respiratory Viral Select Panel; a CE-IVD-marked molecular assay panel for the detection of five common viruses, including those that cause the common cold, bronchiolitis, croup, influenza-like illnesses, and pneumonia.
The molecular assay panel provides results in approximately three hours, testing for Adenovirus, Human Metapneumovirus, Rhinovirus/Enterovirus, and Parainfluenza virus, using highly accurate PCR technology. RNase P and positive controls are included to offer sample-to-result reliability. The solution is scalable, which allows laboratories to run from one to 94 samples simultaneously depending on the needs of the population they’re servicing and can help to identify co-infections.
The TaqPath Respiratory Viral Select Panel is for For In Vitro Diagnostic Use and is only available in select EMEA countries.
